Scientific Sessions 2024  /  Guideline Implementation, Challenges, Success, and Hope  /  Hypertension and AI based clinic guidance
Logo

American Heart Association

  147
  0

Final ID:

Hypertension and AI based clinic guidance

  • Rader, Daniel  ( UNIVERSITY OF PENNSYLVANIA , Philadelphia , Pennsylvania , United States )
  • Khera, Amit  ( UT Southwestern , Dallas , Texas , United States )
  • Kelly, Melissa  ( Geisinger , Danville , Pennsylvania , United States )
  • Ebinger, Joseph  ( Cedars-Sinai Heart Institute , Los Aeles , California , United States )
    • Author Disclosures:
    Daniel Rader: DO have relevant financial relationships ; Consultant:Alnylam:Active (exists now) ; Consultant:Verve:Active (exists now) ; Consultant:Novartis:Active (exists now) | Amit Khera: DO NOT have relevant financial relationships | Melissa Kelly: DO NOT have relevant financial relationships | Joseph Ebinger: DO have relevant financial relationships ; Consultant:Edwards Lifesciences:Active (exists now) ; Consultant:Rubicon Founders:Active (exists now) ; Consultant:Viz.ai:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Guideline Implementation, Challenges, Success, and Hope

Sunday, 11/17/2024 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
SGLT2 guidance in the EHR. Implementation challenges in the EHR.

Lingvay Ildiko, Das Sandeep, Ghazi Lama

Who are guidelines for? The multiple audiences that use guidelines

Martin Seth, Kittleson Michelle

More abstracts from these authors:
Technological Advances in Participant Identification and Trial Enrollment

Ebinger Joseph

How Should We Measure BP in Clinical Trials?

Ebinger Joseph

You have to be authorized to contact abstract author. Please, Login
Not Available